HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Drugstore.com profitability

This article was originally published in The Rose Sheet

Executive Summary

Online retailer achieves first-time EBITDA profitability of $556,000 in the fourth quarter with net sales increasing 28.3% to $70.6 mil., Drugstore.com announces Jan. 20. Strong sales were driven by firm's OTC division, which experienced a 37% sales increase in the quarter. Net loss in the period improved $3.5 mil. to $2.4 mil., President and CEO Kal Raman reports. For the year, firm's net sales increased 26.7% to $245.7 mil., with net loss narrowing to $18.6 mil. from $50.3 mil. Net sales for 2004 are forecast to grow in excess of 45% to $360 mil.-$390 mil., with EBITDA expected to fall between break-even and $4 mil...

Online retailer achieves first-time EBITDA profitability of $556,000 in the fourth quarter with net sales increasing 28.3% to $70.6 mil., Drugstore.com announces Jan. 20. Strong sales were driven by firm's OTC division, which experienced a 37% sales increase in the quarter. Net loss in the period improved $3.5 mil. to $2.4 mil., President and CEO Kal Raman reports. For the year, firm's net sales increased 26.7% to $245.7 mil., with net loss narrowing to $18.6 mil. from $50.3 mil. Net sales for 2004 are forecast to grow in excess of 45% to $360 mil.-$390 mil., with EBITDA expected to fall between break-even and $4 mil....

Latest Headlines
See All
UsernamePublicRestriction

Register

RS011841

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel